Start @ 09:30 Portland, 11:30 Nashville, 12:30 Baltimore, 18.30 Aarhus/Lausanne, 03:30 Brisbane (Tuesday morning, Stowasser group not expected to attend until 6am local)

Time: Dec 12, 2022 11:30 AM Central Time (US and Canada)

Join Zoom Meeting https://zoom.us/j/95509361490

NOTE. TIME ALLOCATION INCLUDES Q&A

12:30-13:25 Baltimore time (18.30 – 19.25 Europe). Welling group (Johns Hopkins)

12:30-12:50 Rick Grimm, Ph.D. Finding the Sweet Spot, Updates

12:50-13:10 Hyun Jun Jung, Ph.D. Updates on DCT remodeling, Finding TF treasures

13:10-13:25 Paul Welling, MD; Summary and plans

Open discussion and break

13:30-14:10 Baltimore time (19.30 – 20.10 Europe). Delpire group (Vanderbilt)

13:30 – 13:50 Eric Delpire, Ph.D: Revisiting the regulation of NCC

13:50 – 14:10 Mohammed Ferdaus, Ph.D. KCC3a and K+ loss in alkalemia

Open discussion and break

14:15-14:45 Baltimore time (20.15 – 20.45 Europe): Fenton group (Aarhus)

14:15-14:30 Søren Poulsen, Ph.D. Glucagon activates NCC in a glucagon receptor-dependent manner

14:30-14:45 Robert Fenton, Ph.D. Summary and plans

Open discussion and break

15:00-15:45 Baltimore time (21.00 – 21.45 Europe). Staub group (Lausanne)

15:00 – 15:20 Olivier Staub, Ph.D. The role of mineralocorticoid receptor in the potassium switch: effect on NCC regulation

15:20-15:40 Alessandro Marazza, PhD. Dissecting the role of PIM kinases in the kidney

Open discussion and break

15:45-16:30 Baltimore time (21.45 – 22.30 Europe). Ellison group (OHSU)

15:00-15:05 Ellison: Introduction

15:05-15:30 Xiao-Tong Su, Ph.D. Post-doctoral fellow,

Four weeks of dietary potassium restriction causes distal convoluted tubule

16:30-17:15 Baltimore time (22.30 – 23.15 Europe, 07.00 – 08.30 Brisbane). Stowasser group

16:30-16:50 Aihua (Nicole) Wu, Ph.D Clinical studies on potassium in hypertension: progress since Boston

16:50-17:10 Michael Stowasser MD. Clinical studies on potassium in hypertension: proposed studies for 2023